Colorectal Cancer Is Rising Sharply Among Young Adults—and Scientists Still Don’t Fully Understand Why
In an era when overall cancer rates have stabilised or declined in many high-income countries and death rates from the disease continue to fall thanks to better treatments and earlier detection, one trend stands out as a clear exception. Colorectal cancer—cancers that begin in the colon or rectum—is increasing among people under the age of 50. The absolute numbers remain relatively low compared with older age groups, yet the steady upward trajectory has left researchers searching for answers that so far remain incomplete.
For decades, colorectal cancer was viewed primarily as a disease of aging. Incidence climbed with age, and public health efforts focused on screening adults aged 50 and older. That picture has shifted. Data from the United States show incidence rising by roughly 2 to 3 percent per year among adults aged 20 to 49. In this younger group, colorectal cancer has become the leading cause of cancer-related death. Similar patterns appear in the United Kingdom and several other high-income nations. Nearly half of all new colorectal cancer diagnoses in the US now occur in people under 65, a striking demographic change from earlier decades.
Researchers describe the pattern as a “birth-cohort effect.” People born after the mid-1950s, and especially those born in the 1980s and 1990s, carry a higher lifetime risk of developing the disease at younger ages than previous generations. Someone born in 1990 faces roughly twice the risk of colon cancer and four times the risk of rectal cancer compared with someone born in 1950. This generational signature suggests that shared environmental or lifestyle exposures experienced by more recent cohorts are playing a role, rather than a simple change in diagnostic practices.
The trend is not universal. Detailed international analyses have found rates of early-onset colorectal cancer stable or even declining in a substantial share of countries examined, including Italy and Lithuania. The inconsistency across nations makes a single global explanation harder to pin down and complicates the search for causes.
Why Common Explanations Fall Short
Several candidate factors have been examined carefully, yet none fully account for the age-specific rise.
Obesity is a well-established risk factor for colorectal cancer. Excess body weight promotes chronic inflammation and hormonal changes that can encourage tumour growth. Younger generations have higher rates of obesity than their predecessors, and this almost certainly contributes. Modelling studies, however, suggest obesity explains only a modest fraction of the increase—perhaps 15 percent or less. Older adults have also become heavier on average, yet their colorectal cancer rates have continued to fall, largely because of screening programmes that remove precancerous polyps. The contrast weakens the idea that obesity alone is driving the youth-specific trend.
Environmental chemicals have drawn attention as well. Certain pesticides, herbicides, and so-called “forever chemicals” (PFAS) have been linked in laboratory and some epidemiological studies to elevated cancer risk. The timing, however, does not line up cleanly. Many of these substances were used more heavily in earlier decades, meaning older generations often experienced greater cumulative exposure. It is difficult to explain why rates would rise in younger people while declining in older ones if widespread chemical exposure were the dominant factor.
Changes in screening guidelines also cannot explain the pattern. In the United States, the recommended starting age for average-risk adults was lowered from 50 to 45 only in recent years. The upward trend in under-50 diagnoses began in the 1990s—well before those changes took effect. Improved cancer registries and greater use of diagnostic testing in younger adults may inflate recorded rates to some degree, but researchers generally regard these as secondary influences rather than the primary drivers.
Diet and lifestyle factors remain under active investigation. High consumption of ultra-processed foods, red and processed meats, low fibre intake, sedentary behaviour, and disrupted sleep patterns have all increased across recent generations. Each is associated with higher colorectal cancer risk in broader studies. Antibiotic use and shifts in the gut microbiome are also being examined closely. The community of bacteria living in the intestine influences inflammation, immune function, and the production of potentially harmful metabolites. Changes in how infants acquire their first gut bacteria—through rising rates of caesarean delivery, formula feeding, or early antibiotic exposure—could theoretically alter long-term cancer risk, though direct evidence is still developing.
Emerging Clues From the Microbiome
One of the more concrete recent findings involves a bacterial toxin called colibactin. Certain strains of E. coli that commonly reside in the human gut produce this compound, which can damage DNA. Genomic analyses of colorectal tumours have revealed distinctive mutation signatures left by colibactin. These signatures appear far more frequently in cancers diagnosed before age 40 than in those diagnosed after 70—roughly three times more common in the younger group.
Timing estimates suggest the damaging exposure often occurs in the first decade of life. A mutation acquired at age five or eight could put an individual decades ahead of the typical schedule for developing colorectal cancer, leading to diagnosis in the 30s or 40s rather than the 60s or 70s. Colibactin-related mutations also appear enriched in countries with higher rates of early-onset disease. While this research does not prove that childhood exposure is the main cause of the rise, it offers a plausible biological mechanism that fits the birth-cohort pattern. Scientists are now exploring how diet, antibiotics, and other factors might influence the abundance of colibactin-producing bacteria.
Broader Context and Practical Implications
Colorectal cancer is not the only malignancy increasing among younger adults. Breast, uterine, kidney, pancreatic, and several other cancers have also shown upward trends in people under 50 in multiple countries. In some analyses, at least 14 to 17 cancer types appear more common in recent generations than in earlier ones at the same ages. The shared pattern has prompted researchers to look for common underlying influences—metabolic changes, early-life exposures, or environmental shifts that began in the postwar decades and intensified thereafter.
Despite the concerning trends, perspective remains important. The vast majority of colorectal cancer cases still occur in older adults. Early-onset disease accounts for a minority of total diagnoses. Survival has improved for many patients because of advances in surgery, chemotherapy, immunotherapy, and targeted drugs. Yet younger patients are more often diagnosed at advanced stages. Symptoms such as rectal bleeding, unexplained changes in bowel habits, persistent abdominal pain, iron-deficiency anaemia, or unexplained weight loss are sometimes attributed to less serious conditions in people under 50, leading to delayed evaluation.
Public health responses have begun to adapt. Screening guidelines now recommend that average-risk adults begin regular testing at age 45. Those with a family history of colorectal cancer, certain genetic syndromes, or inflammatory bowel disease may need to start earlier and undergo more intensive surveillance. Lifestyle measures that lower overall risk remain relevant at any age: maintaining a healthy weight, engaging in regular physical activity, limiting red and processed meat, increasing fibre intake from vegetables, fruits, and whole grains, avoiding tobacco, and moderating alcohol consumption.
The rise of colorectal cancer in younger adults is real, measurable, and incompletely explained. It reflects a genuine shift in risk across generations rather than an artefact of better detection alone. Ongoing research into the gut microbiome, early-life exposures, diet, and environmental factors may eventually identify the key drivers and open pathways for prevention. Until clearer answers emerge, awareness of the trend, attention to persistent symptoms, and adherence to updated screening recommendations offer the most practical tools available.
About The Author
